The FDA has issued public warnings about dosing errors and adverse events involving compounded semaglutide and tirzepatide - with more than 1,700 adverse events linked to compounded semaglutide and tirzepatide combined as of May 21, 2026, according to FDA's published adverse event data
We already know that the hardest working aspect of metformin is how it That excessive production of glucose leads to increased blood glucose levels and an increased need for insulin
What should I do if I miss a dose
Email us your question at [email protected]
This has not been confirmed in humans, and UK SmPCs for licensed GLP-1 receptor agonists classify this as a precaution rather than a contraindication
Conditions such as rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, psoriasis, multiple sclerosis, and other autoimmune disorders are not within the approved therapeutic scope of this medication